How AI is Shortening China's Drug Discovery Cycle: Insilico Medicine Compresses Candidate Drug Development Time to Approximately One Year
Insilico Medicine has reduced the time needed to produce some drug development candidates to about one year by combining artificial intelligence with laboratory research in China, according to CEO Alex Zhavoronkov.
Return to original text
A short introduction is retained here; the full text from the source website is not reposted. For specific wording and subsequent updates, please refer to the original article.
Open artificialintelligence-news.com original